tiprankstipranks
Transgene SA (GB:0OCQ)
LSE:0OCQ
UK Market
0OCQ
Transgene
RESEARCH TOOLSreports

Transgene (0OCQ) Financial Statements

2 Followers

Transgene Financial Overview

Transgene's market cap is currently €213.65M. The company's EPS TTM is €-0.114; its P/E ratio is -3.69; Transgene is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 137.00K€ 6.35M€ 7.90M€ 3.13M€ 9.99M
Gross Profit€ 490.00K€ -27.93M€ -21.69M€ -29.04M€ -22.89M
Operating Income€ -41.07M€ -35.66M€ -30.05M€ -29.90M€ -23.52M
EBITDA€ -39.77M€ -26.65M€ -28.44M€ -30.33M€ -23.55M
Net Income€ -37.52M€ -33.97M€ -22.33M€ -32.81M€ -20.00M
Balance Sheet
Cash & Short-Term Investments€ 111.86M€ 16.67M€ 15.67M€ 26.83M€ 49.57M
Total Assets€ 138.83M€ 42.17M€ 45.22M€ 66.44M€ 101.84M
Total Debt€ 2.06M€ 10.40M€ 1.35M€ 2.45M€ 3.84M
Net Debt€ -4.60M€ -6.44M€ -14.32M€ -1.95M€ -2.07M
Total Liabilities€ 17.09M€ 26.97M€ 29.61M€ 28.59M€ 34.63M
Stockholders' Equity€ 121.73M€ 15.20M€ 15.61M€ 37.84M€ 67.21M
Cash Flow
Free Cash Flow€ -37.58M€ -26.62M€ -37.42M€ -21.84M€ -32.63M
Operating Cash Flow€ -36.74M€ -23.55M€ -34.67M€ -20.30M€ -31.94M
Investing Cash Flow€ -105.95M€ -3.21M€ 34.57M€ 20.27M€ 16.79M
Financing Cash Flow€ 134.38M€ 26.96M€ 11.37M€ -1.48M€ 15.77M
Currency in EUR

Transgene Earnings and Revenue History

Income Statement >

Transgene Debt to Assets

Balance Sheet >

Transgene Cash Flow

Cash Flow >

Transgene Forecast EPS vs Actual EPS

Earnings >